These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 31982048)
1. The antimicrobial crisis: enough advocacy, more action. The Lancet Lancet; 2020 Jan; 395(10220):247. PubMed ID: 31982048 [No Abstract] [Full Text] [Related]
2. New international group on antimicrobial resistance. Zarocostas J Lancet; 2020 Nov; 396(10264):1715. PubMed ID: 33248486 [No Abstract] [Full Text] [Related]
3. Stop delaying action on antimicrobial resistance - it is achievable and affordable. Laxminarayan R Nature; 2024 Sep; 633(8030):495. PubMed ID: 39289500 [No Abstract] [Full Text] [Related]
4. Drug development: Time for teamwork. May M Nature; 2014 May; 509(7498):S4-5. PubMed ID: 24784427 [No Abstract] [Full Text] [Related]
5. 'Tax pharma companies if they fail to act on AMR', says Review chief Lord O'Neill. Vet Rec; 2018 Jun; 182(26):728. PubMed ID: 29954991 [No Abstract] [Full Text] [Related]
6. Antimicrobial Stewardship and Antimicrobial Resistance. Rice LB Med Clin North Am; 2018 Sep; 102(5):805-818. PubMed ID: 30126572 [TBL] [Abstract][Full Text] [Related]
7. What are the economic barriers of antibiotic R&D and how can we overcome them? Renwick M; Mossialos E Expert Opin Drug Discov; 2018 Oct; 13(10):889-892. PubMed ID: 30175625 [No Abstract] [Full Text] [Related]
8. The antibiotic pipeline--challenges, costs, and values. Wenzel RP N Engl J Med; 2004 Aug; 351(6):523-6. PubMed ID: 15295041 [No Abstract] [Full Text] [Related]
9. Human resources estimates and funding for antibiotic stewardship teams are urgently needed. Pulcini C; Morel CM; Tacconelli E; Beovic B; de With K; Goossens H; Harbarth S; Holmes A; Howard P; Morris AM; Nathwani D; Sharland M; Schouten J; Thursky K; Laxminarayan R; Mendelson M Clin Microbiol Infect; 2017 Nov; 23(11):785-787. PubMed ID: 28778544 [No Abstract] [Full Text] [Related]
10. A three-step plan for antibiotics. Nature; 2014 May; 509(7502):533. PubMed ID: 24877183 [No Abstract] [Full Text] [Related]
11. Antimicrobial resistance stewardship: it's up to us all. Santy-Tomlinson J Int J Orthop Trauma Nurs; 2018 Feb; 28():1-3. PubMed ID: 29254752 [No Abstract] [Full Text] [Related]
12. Pay drug companies $1bn for each new antibiotic, says report. Owen J BMJ; 2016 May; 353():i2863. PubMed ID: 27198868 [No Abstract] [Full Text] [Related]
13. Antibiotics: a shot in the arm. Leeb M Nature; 2004 Oct; 431(7011):892-3. PubMed ID: 15496888 [No Abstract] [Full Text] [Related]
14. The antibacterial drugs market. Kresse H; Belsey MJ; Rovini H Nat Rev Drug Discov; 2007 Jan; 6(1):19-20. PubMed ID: 17269159 [No Abstract] [Full Text] [Related]
15. A Global Strategy for the Management of Surgical Infections. Rickard J; Beilman G Surg Infect (Larchmt); 2020 Aug; 21(6):477. PubMed ID: 32228368 [No Abstract] [Full Text] [Related]
16. Antibiotics at the crossroads. Nathan C Nature; 2004 Oct; 431(7011):899-902. PubMed ID: 15496893 [No Abstract] [Full Text] [Related]
17. Report urges controversial 'delinkage' to foster new antibiotics. Holmes D Nat Med; 2014 Apr; 20(4):320. PubMed ID: 24710363 [No Abstract] [Full Text] [Related]
18. Sustainable Discovery and Development of Antibiotics - Is a Nonprofit Approach the Future? Nielsen TB; Brass EP; Gilbert DN; Bartlett JG; Spellberg B N Engl J Med; 2019 Aug; 381(6):503-505. PubMed ID: 31216396 [No Abstract] [Full Text] [Related]
19. The antibiotics market. Hamad B Nat Rev Drug Discov; 2010 Sep; 9(9):675-6. PubMed ID: 20811374 [No Abstract] [Full Text] [Related]
20. Antibiotic stewardship: a European perspective. Pulcini C FEMS Microbiol Lett; 2017 Dec; 364(23):. PubMed ID: 29092037 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]